Annual Long Term Debt
$0.00
-$163.00 K-100.00%
31 December 2022
Summary:
Nymox Pharmaceutical annual long term debt is currently $0.00, with the most recent change of -$163.00 thousand (-100.00%) on 31 December 2022. During the last 3 years, it has fallen by -$233.00 thousand (-100.00%).NYMX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$0.00
$0.000.00%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly long term debt is currently $0.00, unchanged on 31 March 2023.NYMX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -100.0% | -100.0% |
5 y5 years | 0.0% | -100.0% |
NYMX Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -100.0% | -100.0% |
Nymox Pharmaceutical Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $0.00(0.0%) |
Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2022 | - | $11.00 K(-78.8%) |
June 2022 | - | $52.00 K(-51.9%) |
Mar 2022 | - | $108.00 K(-33.7%) |
Dec 2021 | $163.00 K(-30.0%) | $163.00 K(-63.4%) |
Sept 2021 | - | $445.00 K(+45.0%) |
June 2021 | - | $307.00 K(-9.2%) |
Mar 2021 | - | $338.00 K(+45.1%) |
Dec 2020 | $233.00 K(+7666.7%) | $233.00 K(>+9900.0%) |
Sept 2020 | - | $0.00(-100.0%) |
June 2020 | - | $102.00 K(-17.7%) |
Mar 2020 | - | $124.00 K(+4033.3%) |
Dec 2019 | $3000.00(>+9900.0%) | $3000.00(-98.0%) |
Sept 2019 | - | $148.00 K(-37.8%) |
June 2019 | - | $238.00 K(-15.6%) |
Mar 2019 | - | $282.00 K(>+9900.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
Mar 2017 | - | $964.30 K(+7.2%) |
Sept 2016 | - | $899.20 K(+3.4%) |
June 2016 | - | $869.40 K(+3.3%) |
Mar 2016 | - | $841.30 K(+6.5%) |
Sept 2015 | - | $789.60 K(+3.1%) |
June 2015 | - | $765.80 K(+3.0%) |
Mar 2015 | - | $743.40 K(+3.4%) |
Dec 2014 | $718.80 K(+4392.5%) | $718.80 K(+8068.2%) |
Sept 2008 | - | $8800.00(-21.4%) |
June 2008 | - | $11.20 K(-17.6%) |
Mar 2008 | - | $13.60 K(-15.0%) |
Dec 2007 | $16.00 K(-37.7%) | $16.00 K(-13.5%) |
Sept 2007 | - | $18.50 K(-28.0%) |
Dec 2006 | $25.70 K | $25.70 K(-74.2%) |
June 1999 | - | $99.50 K |
FAQ
- What is Nymox Pharmaceutical annual long term debt?
- What is the all time high annual long term debt for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly long term debt?
- What is the all time high quarterly long term debt for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual long term debt?
The current annual long term debt of NYMX is $0.00
What is the all time high annual long term debt for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual long term debt is $718.80 K
What is Nymox Pharmaceutical quarterly long term debt?
The current quarterly long term debt of NYMX is $0.00
What is the all time high quarterly long term debt for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly long term debt is $964.30 K